The aim of this study was to evaluate the indications and the results of secondary cytoreduction surgery with intraperitoneal (i.p.) paclitaxel chemotherapy in advanced or recurrent epithelial ovarian cancer.
PATIENTS AND METHODS
In a retrospective study, records were reviewed for 13 patients who received i.p. paclitaxel therapy (175 mg/m2… (More)